Georgia Statutes
§ 31-52-4 — Eligibility criteria
Georgia § 31-52-4
JurisdictionGeorgia
Title31
This text of Georgia § 31-52-4 (Eligibility criteria) is published on Counsel Stack Legal Research, covering Georgia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
O.C.G.A. § 31-52-4 (2026).
Text
In order for a person to be considered an eligible patient to access an investigational drug, biological product, or device pursuant to this chapter, a physician must document in writing that the person:
(1)Has a terminal illness;
(2)Has, in consultation with the physician, considered all other treatment options currently approved by the federal Food and Drug Administration;
(3)Has been given a recommendation by the physician for an investigational drug, biological product, or device; and (4) Has given written informed consent for the use of the investigational drug, biological product, or device.
Free access — add to your briefcase to read the full text and ask questions with AI
Legislative History
Added by 2016 Ga. Laws 422,§ 1, eff. 7/1/2016.
Nearby Sections
15
§ 31-1-1
Definitions§ 31-1-10
State health officer; duties§ 31-1-13
Hemophilia Advisory Board§ 31-1-17
Notification of dense breast tissue§ 31-1-20
through 31-1-22 - ReservedCite This Page — Counsel Stack
Bluebook (online)
Georgia § 31-52-4, Counsel Stack Legal Research, https://law.counselstack.com/statute/ga/31-52-4.